Latest Insider Transactions at Immix Biopharma, Inc. (IMMX)
This section provides a real-time view of insider transactions for Immix Biopharma, Inc. (IMMX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Immix Biopharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Immix Biopharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 20
2021
|
Vladimir P Torchilin Scientific Co-Founder |
BUY
Open market or private purchase
|
Direct |
3,000
+0.33%
|
$15,000
$5.0 P/Share
|
|
Dec 20
2021
|
Jason Hsu Director |
BUY
Open market or private purchase
|
Indirect |
50,000
+50.0%
|
$250,000
$5.0 P/Share
|
|
Dec 20
2021
|
Jason Hsu Director |
BUY
Conversion of derivative security
|
Indirect |
3,915,913
+50.0%
|
$0
$0.85 P/Share
|
|
Dec 20
2021
|
Ilya M Rachman CEO and Chairman |
BUY
Open market or private purchase
|
Direct |
2,500
+0.28%
|
$12,500
$5.0 P/Share
|
|
Dec 17
2021
|
Vladimir P Torchilin Scientific Co-Founder |
BUY
Open market or private purchase
|
Direct |
2,200
+0.24%
|
$8,800
$4.47 P/Share
|